Search results for "INCIDENCE"

showing 10 items of 2270 documents

Impact of Italian Score for Organ Allocation System on Deceased Donor Liver Transplantation: A Monocentric Competing Risk Time-to-Event Analysis

2019

Background: Liver transplantation (LT) is the only definitive and curative treatment for patients with end-stage liver disease and hepatocellular carcinoma. We aimed to evaluate the impact of the Italian score for organ allocation (ISO) in terms of the waiting-list mortality, probability of LT, and patient survival after LT. Patient and methods: All of the adult patients on the waiting list for LT at our institute from January 2014 to December 2017 were included in the study. The probabilities of death while on the waiting list, dropout from the list, and LT were compared by means of cumulative incidence functions, in a competing risk time-to-event analysis setting. Uni- and multivariable l…

AdultMalemedicine.medical_specialtyCarcinoma HepatocellularTime FactorsWaiting Listsmedicine.medical_treatmentLiver transplantationCompeting risksLogistic regressionSeverity of Illness IndexGroup BEnd Stage Liver DiseaseLiver diseaseRisk FactorsInternal medicinemedicineHumansCumulative incidenceSurvival analysisRetrospective StudiesTransplantationbusiness.industryLiver NeoplasmsMiddle Agedmedicine.diseaseLiver TransplantationItalyHepatocellular carcinomaSurgeryFemalebusiness
researchProduct

Primary pulmonary sarcomas: Etiology, clinical assessment and prognosis with a comparison to pulmonary carcinomas —A review of 41 cases and 394 other…

1982

Primary sarcomas of the lungs occur at frequencies of 1:100, as compared with carcinomas reported in our retrospective studies covering 394 cases reported in the literature from 1957 to 1972 and 41 cases from 1957 to 1974. The average age was 45 years, the disease usually occurred between the ages of 35 and 65, the peak being between 45 and 60 years. Distribution between sexes was much the same as that seen in general. X-ray with rapid thoracotomy provided the best clinical results. The literature showed a postoperative survival time of 5 years in 19% and 44% of our own cases. The general metastasis, haematologenous and lymphogenous were more or less equal and recidive tendency in 7% essent…

AdultMalemedicine.medical_specialtyChronic bronchitisPathologyLung NeoplasmsAdolescentmedicine.medical_treatmentGastroenterologyMetastasisJapanInternal medicinemedicineCarcinomaHumansThoracotomyChildAgedbusiness.industryIncidence (epidemiology)CarcinomaSmokingAge FactorsInfantSarcomaRetrospective cohort studyGeneral MedicineMiddle AgedPrognosismedicine.diseaseChild PreschoolEtiologyFemaleSurgerySarcomabusinessThe Japanese Journal of Surgery
researchProduct

Incidence, Presentation, and Prognosis of Small Bowel Adenocarcinoma in Patients with Small Bowel Crohn's Disease: A Prospective Observational Study.

2013

International audience; BACKGROUND:: Patients with Crohn's disease (CD) of the colon are at risk for colorectal cancer and should be screened for dysplasia and cancer of the colon. Small bowel adenocarcinoma (SBA) is a complication of small bowel CD and carries a poor prognosis. However, there is no screening test for SBA in patients with small bowel CD. The aim of this study was to assess the risk and incidence of SBA in a large prospective cohort of patients with small bowel CD and to compare it with the risk of colorectal cancer in patients with CD involving the colon, recruited in the same cohort. METHODS:: In a nationwide French cohort, 11,759 patients with CD were enrolled by 680 gast…

AdultMalemedicine.medical_specialtyColorectal cancerPopulationAdenocarcinomaGastroenterology03 medical and health sciences0302 clinical medicineCrohn DiseaseInterquartile rangeRisk Factors[ CHIM.ORGA ] Chemical Sciences/Organic chemistryInternal medicinemedicineImmunology and AllergyHumansProspective StudieseducationProspective cohort studyCrohn's diseaseeducation.field_of_studybusiness.industry[CHIM.ORGA]Chemical Sciences/Organic chemistryIncidence (epidemiology)IncidenceGastroenterologyCancerMiddle Agedmedicine.diseasePrognosisdigestive system diseasesIleal Neoplasms030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologyFemaleFrancebusinessColorectal NeoplasmsFollow-Up Studies
researchProduct

Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.

2015

Background This study aimed to characterize the dynamics of acquisition of cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) in CMV donor positive/recipient negative solid organ transplant (SOT) patients receiving long-term antiviral prophylaxis, and to determine whether development of CMI confers protection against CMV disease. Methods A prospective multicenter study was conducted in Spain from September 2009 to September 2012. Whole blood specimens were prospectively collected at 30, 90, 120, 200, and 365 days after SOT, and CMI was determined by enumeration of CMV pp65 and IE-1-specific CD69+/interferon-γ-producing CD8+ and CD4+ T cells by flow cytometry for intracellular cytok…

AdultMalemedicine.medical_specialtyCongenital cytomegalovirus infectionCytomegalovirusDiseaseKaplan-Meier EstimateGastroenterologyAntiviral AgentsPostoperative ComplicationsImmunityInternal medicinemedicineHumansValganciclovirProspective StudiesGanciclovirSurvival analysisAgedPostoperative CareTransplantationImmunity Cellularbusiness.industryIncidence (epidemiology)Organ TransplantationMiddle Agedmedicine.diseaseTransplantationClinical trialInfectious DiseasesTreatment OutcomeImmunologyCytomegalovirus InfectionsFemalebusinessCD8Follow-Up StudiesTransplant infectious disease : an official journal of the Transplantation Society
researchProduct

Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic …

2020

<b><i>Purpose:</i></b> The coronavirus disease 2019 (COVID-19) pandemic is disrupting urology health-care worldwide. Reduced emergency room visits resulting in adverse outcomes have most recently been reported in pediatrics and cardiology. We aimed to compare patients with emergency room visits for pyelonephritis in 2019 (pre-COVID-19 era) and within the first wave of pandemic in 2020 (COVID-19 era) with regard to the number of visits and severe adverse disease outcomes. <b><i>Methods:</i></b> We performed a retrospective multicentre study comparing characteristics and outcomes of patients with pyelonephritis, excluding patients with hydroneph…

AdultMalemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Adverse outcomesUrologymedicine.medical_treatment030232 urology & nephrologyUrologyComorbiditySide effect03 medical and health sciencesYoung Adult0302 clinical medicineInformation campaignGermanyPandemicmedicineHumansHydronephrosisPandemicsStone diseaseRetrospective StudiesOutcomePyelonephritisbusiness.industrySARS-CoV-2IncidenceCOVID-19Middle Agedmedicine.diseaseNephrectomyHospitalizationCoronavirus030220 oncology & carcinogenesis2019-nCoVCollateral damageFemaleMorbiditybusinessEmergency Service HospitalResearch ArticleUrinary infectionUrologia internationalis
researchProduct

Atrial Fibrillation Manifestations Risk Factors and Sex Differences in a Population-Based Cohort (From the Gutenberg Health Study)

2018

Sex differences in cardiovascular risk factors, cardiac structure and function, and disease and symptom burden in the common arrhythmia atrial fibrillation (AF) have not been investigated systematically at the population level. Cross-sectional data of 14,796 subjects (age range 35 to 74 years, 50.5% men) from the population-based Gutenberg Health Study were examined to show the distribution of cardiovascular risk factors by AF status and sex, and to determine sex-specific predictors for AF. The prevalence of AF was higher in men (4.3%) than in women (1.9%). Men had a worse cardiovascular risk factor profile, a higher prevalence of cardiovascular disease, but fewer symptoms than women. Age-a…

AdultMalemedicine.medical_specialtyCross-sectional studyHeart VentriclesPopulation030204 cardiovascular system & hematologyRisk AssessmentVentricular Function LeftCoronary artery diseaseElectrocardiography03 medical and health sciencesSex Factors0302 clinical medicineRisk FactorsGermanyInternal medicineAtrial FibrillationPrevalenceHumansMedicine030212 general & internal medicineMyocardial infarctionRisk factoreducationAgedRetrospective Studieseducation.field_of_studybusiness.industryIncidenceRetrospective cohort studyAtrial fibrillationOdds ratioMiddle Agedmedicine.disease3. Good healthSurvival RateCross-Sectional StudiesEchocardiographyPopulation SurveillanceCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe American Journal of Cardiology
researchProduct

Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5.

2020

Arrhythmogenic right ventricular cardiomyopathy type V (ARVC-5) is the most aggressive heterozygous form of ARVC. It is predominantly caused by a fully penetrant mutation (p.S358L) in the nondesmosomal gene TMEM43-endemic to Newfoundland, Canada. To date, all familial cases reported worldwide share a common ancestral haplotype. It is unknown whether the p.S358L mutation by itself causes ARVC-5 or whether the disease is influenced by genetic or environmental factors. The purpose of this study was to examine the phenotype, clinical course, and the impact of exercise on patients with p.S358L ARVC-5 without the Newfoundland genetic background. We studied 62 affected individuals and 73 noncarrie…

AdultMalemedicine.medical_specialtyDNA Mutational AnalysisMutation MissenseDisease030204 cardiovascular system & hematologyVentricular Function LeftRight ventricular cardiomyopathySudden cardiac deathElectrocardiography03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicinemedicineGeneticsHumans030212 general & internal medicineExerciseArrhythmogenic Right Ventricular DysplasiaEjection fractionTMEM43business.industryIncidence (epidemiology)HaplotypeMembrane ProteinsStroke VolumeDNAmedicine.diseasePhenotypePedigree3. Good healthPhenotypeMutation (genetic algorithm)CardiologyFemaleCardiology and Cardiovascular MedicinebusinessArrhythmogenic right ventricular cardiomyopathyArrhythmia
researchProduct

Hereditary angioedema with normal C1-INH withversuswithout specificF12gene mutations

2015

Background Hereditary angioedema with normal C1-INH may be linked to specific mutations in the coagulation factor 12 (FXII) gene (HAE-FXII) or mutations in genes that are still unknown (HAE-unknown). To assess the differences in transmission and inheritance, clinical features, and laboratory parameters between patients with HAE-FXII and HAE-unknown. Methods Sixty-nine patients with HAE-FXII from 23 unrelated families and 196 patients with HAE-unknown from 65 unrelated families were studied. Results Both HAE-FXII and HAE-unknown are inherited as autosomal-dominant traits with incomplete penetrance. The male to female ratio was 1 : 68 in HAE-FXII and 1 : 6.3 in HAE-unknown. The maternal to pa…

AdultMalemedicine.medical_specialtyDatabases FactualOffspringImmunologyGene mutationSeverity of Illness IndexCohort StudiesYoung Adultchemistry.chemical_compoundAge DistributionInternal medicineHumansImmunology and AllergyMedicineHereditary Angioedema Type IIIAge of OnsetSex DistributionRetrospective Studiesmedicine.diagnostic_testAngioedemabusiness.industryIncidenceAngioedemas HereditaryMiddle AgedPrognosismedicine.diseasePenetranceRecombinant ProteinsPedigreePhenotypeEndocrinologychemistryPlasminogen activator inhibitor-1Factor XIIMutationHereditary angioedemaFemalemedicine.symptombusinessComplement C1 Inhibitor ProteinPartial thromboplastin timeAllergy
researchProduct

Monozygotic twinning after assisted reproductive technologies: a case report of asymmetric development and incidence during 19 years in an internatio…

2015

Objective To describe a case of monozygotic twinning with asymmetric development following a single fresh embryo transfer as part of an intracytoplasmic sperm injection (ICSI) treatment. Secondarily, to report the incidence of monozygotic twinning at the IVI (Instituto Valenciano de Infertilidad) clinics. Design Case report. Setting Private fertility centers. Patient(s) A 33-year-old woman with a 2-year history of primary infertility. Intervention(s) Controlled ovarian hyperstimulation and ICSI treatment with single-embryo transfer. Main Outcome Measure(s) Incidence of monozygotic twinning at the IVI clinics. Result(s) We report a twin pregnancy after a single-embryo transfer. Twins were di…

AdultMalemedicine.medical_specialtyDatabases FactualReproductive Techniques Assistedmedia_common.quotation_subjectmedicine.medical_treatmentFertilityReproductive technologyControlled ovarian hyperstimulationUltrasonography PrenatalIntracytoplasmic sperm injectionOvulation InductionPredictive Value of TestsPregnancySingle Embryo TransfermedicineHumansGenetic TestingSperm Injections IntracytoplasmicInfertility MaleTwin Pregnancymedia_commonGynecologyPregnancyIn vitro fertilisationTwinning Monozygoticbusiness.industryIncidence (epidemiology)Obstetrics and GynecologyTwins Monozygoticmedicine.diseaseFertilityTreatment OutcomeReproductive MedicinePregnancy TwinFemalebusinessLive BirthFertility and Sterility
researchProduct

Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital

2015

Drug-induced agranulocytosis is a rare haematological disorder considered as severe adverse drug reaction. Due to its low incidence, the number of studies are low and the variability of clinical features and presentation in hospitalized patients is rarely described. Awe performed an observational, transversal and retrospective study in the haematology and toxicology unit in a tertiary hospital located in Spain (Valencia) (1996–2010) in order to assess its incidence, the drugs involved, the management and outcomes of drug-induced agranulocytosis. Twenty-one cases of agranulocytosis were retrieved. All of them presented severe and symptomatic agranulocytosis (fever and infection). The most c…

AdultMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsItraconazoleHealth Toxicology and Mutagenesis030204 cardiovascular system & hematologyToxicologyTertiary Care CentersLeukocyte Count03 medical and health sciences0302 clinical medicineSulfasalazineInternal medicineGranulocyte Colony-Stimulating FactormedicineHumans030212 general & internal medicineAgedAged 80 and overbusiness.industryIncidenceIncidence (epidemiology)Retrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseMetamizoleSpainAbsolute neutrophil countFemalebusinessCefuroximeAdverse drug reactionAgranulocytosismedicine.drugHuman & Experimental Toxicology
researchProduct